Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
complement factor I | 0.569 | 0.731 | 3.5E-08 |
|
disease | 0.110 | None | 0.500 | 1 | 2 | 2014 | 2016 | ||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2016 | 2017 | |||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2010 | 2016 | ||||||||
|
glycosyltransferase 6 domain containing 1 | 0.861 | 0.038 | 0.12 |
|
disease | 0.120 | None | 0.500 | 1 | 1 | 2010 | 2014 | ||||||||
|
potassium calcium-activated channel subfamily N member 4 | 0.653 | 0.577 | 5.0E-07 |
|
disease | 0.110 | None | 0.500 | 1 | 2 | 2016 | 2017 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2015 | 2018 | ||||||||
|
lipase A, lysosomal acid type | 0.564 | 0.654 | 5.5E-07 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2013 | 2015 | ||||||||
|
transient receptor potential cation channel subfamily M member 1 | 0.626 | 0.462 | 1.6E-42 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2011 | 2018 | ||||||||
|
zinc finger homeobox 3 | 0.621 | 0.654 | 0.45 |
|
group | 0.130 | None | 0.500 | 1 | 1 | 2007 | 2017 | ||||||||
|
NADH:ubiquinone oxidoreductase core subunit S3 | 0.581 | 0.769 | 5.8E-04 |
|
phenotype | 0.110 | None | 0.500 | 1 | 1 | 2018 | 2019 | ||||||||
|
endoplasmic reticulum aminopeptidase 2 | 0.615 | 0.577 | 1.0E-28 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2007 | 2015 | ||||||||
|
protocadherin related 15 | 0.601 | 0.577 | 8.0E-25 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2016 | 2019 | ||||||||
|
steroid 5 alpha-reductase 2 | 0.564 | 0.615 |
|
disease | 0.430 | None | 0.500 | 1 | 2 | 2003 | 2017 | |||||||||
|
ring finger protein 146 | 0.705 | 0.577 | 0.82 |
|
disease | 0.140 | None | 0.500 | 1 | 1 | 2008 | 2011 | ||||||||
|
zinc finger RANBP2-type containing 3 | 0.780 | 0.577 | 4.2E-21 |
|
disease | 0.120 | None | 0.500 | 1 | 1 | 2019 | 2019 | ||||||||
|
plexin domain containing 2 | 0.736 | 0.269 | 0.13 |
|
disease | 0.120 | None | 0.500 | 1 | 1 | 2011 | 2015 | ||||||||
|
solute carrier family 25 member 12 | 0.711 | 0.462 | 0.22 |
|
disease | 0.410 | None | 0.500 | 1 | 1 | 2007 | 2019 | ||||||||
|
fasciculation and elongation protein zeta 1 | 0.666 | 0.500 | 0.75 |
|
disease | 0.410 | None | 0.500 | 1 | 1 | 2004 | 2013 | ||||||||
|
transcription factor 4 | 0.464 | 0.846 | 1.00 |
|
disease | 0.450 | None | 0.600 | 1 | 1 | 1999 | 2013 | ||||||||
|
spectrin repeat containing nuclear envelope protein 1 | 0.511 | 0.846 | 3.2E-52 |
|
disease | 0.450 | None | 0.667 | 6 | 4 | 2011 | 2019 | ||||||||
|
fasciculation and elongation protein zeta 1 | 0.666 | 0.500 | 0.75 |
|
disease | 0.500 | None | 0.667 | 3 | 2 | 2004 | 2017 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
group | 0.110 | None | 0.667 | 2 | 2 | 2010 | 2012 | ||||||||
|
mitogen-activated protein kinase kinase kinase 8 | 0.516 | 0.846 | 0.97 |
|
group | 0.110 | None | 0.667 | 2 | 1 | 2007 | 2017 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
disease | 0.110 | None | 0.667 | 2 | 2 | 2010 | 2017 | ||||||||
|
cytochrome P450 family 26 subfamily B member 1 | 0.666 | 0.500 | 0.98 |
|
disease | 0.410 | None | 0.667 | 2 | 1 | 2009 | 2015 |